| Literature DB >> 35280163 |
Kerstin Spanhel1, Eva Hovestadt1, Dirk Lehr2, Kai Spiegelhalder3, Harald Baumeister4, Juergen Bengel1, Lasse B Sander1.
Abstract
Refugees are exposed to multiple stressors affecting their mental health. Given various barriers to mental healthcare in the arrival countries, innovative healthcare solutions are needed. One such solution could be to offer low-threshold treatments, for example by culturally adapting treatments, providing them in a scalable format, and addressing transdiagnostic symptoms. This pilot trial examined the feasibility, acceptance, and preliminary effectiveness of a culturally adapted digital sleep intervention for refugees. Sixty-six refugees participated, with 68.2% of them seeking psychological help for the first time. Only three participants did not show clinically significant insomnia severity, 93.9% reported past traumatic experiences. Participants were randomly assigned to the intervention group (IG) or the waitlist control group (CG). Insomnia severity, measured by the Insomnia Severity Index, and secondary outcomes (sleep quality, fear of sleep, fatigue, depression, wellbeing, mental health literacy) were assessed at baseline, 1 and 3 months after randomization. The self-help intervention included four modules on sleep hygiene, rumination, and information on mental health conditions associated with sleep disturbances. 66.7% of the IG completed all modules. Satisfaction with the intervention and its perceived cultural appropriateness were high. Linear multilevel analyses revealed a small, non-significant intervention effect on insomnia severity of Hedge's g = 0.28 at 3-months follow-up, comparing the IG to the CG [F 2, 60 = 0.88, p = 0.421]. This non-confirmatory pilot trial suggests that low-threshold, viable access to mental healthcare can be offered to multiple burdened refugees by culturally adapting an intervention, providing it in a scalable format, and addressing a transdiagnostic symptom.Entities:
Keywords: culturally sensitive treatment; healthcare barriers; internet-based interventions; low-threshold treatment; refugees; sleep disturbances; transdiagnostic symptoms
Year: 2022 PMID: 35280163 PMCID: PMC8905517 DOI: 10.3389/fpsyt.2022.832196
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Contents of the four modules of the culturally adapted digital sleep intervention eSano Sleep-e.
|
|
|
|---|---|
| Module 1 | Introduction by a health expert, psychoeducation on sleep problems, reflecting on reasons to participate, relaxation exercise, offer to keep an online sleep diary |
| Module 2 | Psychoeducation on sleep hygiene, exercise on sleep hygiene rules, psychoeducation on sleep medication, relaxation exercise, sleep diary |
| Module 3 | Psychoeducation on rumination, exercises to deal with rumination, relaxation exercise, exercise on sleep hygiene rules, sleep diary |
| Module 4 | Psychoeducation on problems related to sleep problems, information on mental healthcare options, reflecting on reasons to continue with exercises, relaxation exercise, reflecting on achievements, exercise on sleep hygiene rules, sleep diary |
Figure 1Study flow chart.
Sociodemographic and baseline characteristics of study participants.
|
|
|
|
|
|---|---|---|---|
| Age in years, mean (SD) | 28.5 (6.8) | 29.2 (6.9) | 27.7 (6.6) |
| Gender, female, | 18 (27.3) | 10 (30.3) | 8 (24.2) |
| In a relationship, married, | 26 (39.4) | 9 (27.3) | 17 (51.5) |
| No qualification/ primary school | 6 (9.1) | 2 (6.1) | 4 (12.1) |
| Middle school | 11 (16.7) | 6 (18.2) | 5 (15.2) |
| High school/ university degree | 49 (74.2) | 25 (75.8) | 24 (72.7) |
| Employed | 24 (36.4) | 13 (39.4) | 11 (33.3) |
| Student | 25 (37.9) | 11 (33.3) | 14 (42.4) |
| House wife/husband, unemployed | 16 (24.2) | 8 (24.2) | 8 (24.2) |
| Years in Germany, mean (SD) | 4.7 (1.5) | 4.8 (1.5) | 4.7 (1.6) |
| Language eSano Sleep-e, German, | 56 (84.8) | 30 (90.6) | 26 (78.8) |
| Beginner, elementary | 2 (3.0) | 1 (3.0) | 1 (3.0) |
| Intermediate, upper-intermediate | 26 (39.4) | 14 (42.4) | 12 (36.5) |
| Pre-advanced, advanced | 36 (54.6) | 18 (54.5) | 18 (54.5) |
| Current use of psychotherapy, | 13 (19.7) | 3 (9.1) | 10 (30.3) |
| No | 45 (68.2) | 21 (63.3) | 24 (72.2) |
| Internet/counseling center | 8 (12.1) | 5 (15.2) | 3 (9.1) |
| Doctor/psychotherapist | 17 (25.8) | 9 (27.3) | 8 (24.2) |
| Insomnia (ISI) | |||
| Not clinical | 3 (4.5) | 3 (9.1) | 0 (0.0) |
| Subthreshold | 30 (45.5) | 13 (39.4) | 17 (51.5) |
| Clinical–moderate | 27 (40.9) | 15 (45.5) | 12 (36.4) |
| Clinical–severe | 6 (9.1) | 2 (6.1) | 4 (12.1) |
| Traumatic experience | 62 (93.9) | 31 (93.9) | 31 (93.9) |
| Alcohol and drug abuse | 14 (21.2) | 6 (18.2) | 8 (24.2) |
| Birth country ( | Syria (39), Afghanistan (6), Turkey (3), United Arab Emirates (3), Iraq (2), Nigeria (2), Gambia (2), | ||
| Sierra Leone (2), Libanon (2), Iran (1), Eritrea (1), Somalia (1), Egypt (1), Sudan (1) | |||
| Native language ( | Arabic (40), Kurdish (5), Kurdish + Arabic (3), Persian (3), Dari (2), Mandinka (2), Paschtu (2), | ||
| Turkish (2), Edo (1), Igbo (1), Krio (1), Kurdish + Turkish (1), Somali (1), Temne (1), Tigrinya (1) | |||
IG, intervention group; CG, control group; SD, standard deviation; ISI, Insomnia Severity Index (.
language skills according to the language of participation in the study (English/German);
ISI total score categories: 0–7, no clinically significant insomnia; 8–14, subthreshold insomnia; 15–21, clinical insomnia (moderate); 22–28, clinical insomnia (severe).
Results for the primary outcome measured by the Insomnia Severity Index (82).
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| T1 | 33 | 14.7 (5.2) | 33 | 15.2 (5.2) | ||||
| T2 | 27 | 12.0 (6.5) | 28 | 14.2 (5.0) | -2.1 (-4.8–0.5) | 0.112 | 0.40 (-0.09–0.88) | |
| T3 | 28 | 11.5 (5.0) | 29 | 12.9 (5.0) | -1.6 (-4.3–1.2) | 0.257 | 0.28 (-0.20–0.77) | |
IG, intervention group; CG, control group; SD, standard deviation; CI, confidence interval; T1, Baseline assessment; T2, 1-month follow-up assessment; T3, 3-months follow-up assessment.
Results for the secondary outcomes.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| ||||||
| T1 | 33 | 9.3 (3.2) | 33 | 10.0 (3.7) | ||
| T2 | 27 | 7.9 (4.0) | 28 | 9.2 (4.3) | -1.0 (-3.0–1.0) | 0.26 (-0.23–0.74) |
| T3 | 28 | 6.8 (3.8) | 29 | 8.9 (3.6) | -1.8 (-3.8–0.3) | 0.42 (-0.07–0.91) |
|
| ||||||
| T1 | 33 | 10.0 (10.6) | 33 | 10.1 (12.2) | ||
| T2 | 27 | 7.7 (9.4) | 28 | 8.0 (12.0) | -1.1 (-6.5–4.4) | 0.10 (-0.39–0.58) |
| T3 | 28 | 7.4 (9.3) | 29 | 6.4 (9.9) | 0.3 (-5.0–5.6) | -0.03 (-0.51–0.46) |
|
| ||||||
| T1 | 33 | 9.0 (3.7) | 33 | 9.0 (3.1) | ||
| T2 | 27 | 7.7 (4.0) | 28 | 8.8 (3.5) | -1.0 (-2.8–0.8) | 0.26 (-0.22–0.75) |
| T3 | 28 | 7.2 (3.7) | 29 | 8.5 (3.1) | -1.5 (-3.3–0.3) | 0.40 (-0.08–0.89) |
|
| ||||||
| T1 | 33 | 8.1 (3.8) | 33 | 7.5 (3.5) | ||
| T2 | 27 | 7.3 (4.0) | 28 | 8.3 (4.6) | -0.9 (-2.9–1.2) | 0.21 (-0.27–0.70) |
| T3 | 28 | 6.2 (4.0) | 29 | 8.4 (3.3) | -2.1 (-4.0–0.2) | 0.53 (0.04–1.02) |
|
| ||||||
| T1 | 33 | 8.8 (4.0) | 33 | 9.0 (4.8) | ||
| T2 | 27 | 7.6 (4.3) | 28 | 9.1 (4.0) | -1.2 (-3.2–0.9) | 0.28 (-0.20–0.77) |
| T3 | 28 | 7.8 (4.2) | 29 | 8.1 (4.0) | -0.6 (-2.9–1.8) | 0.11 (-0.37–0.60) |
|
| ||||||
| T1 | 33 | 8.6 (3.6) | 33 | 9.0 (3.9) | ||
| T2 | 27 | 7.6 (3.9) | 28 | 8.7 (4.7) | -1.1 (-3.3–1.0) | 0.26 (-0.22–0.75) |
| T3 | 28 | 7.5 (4.3) | 29 | 7.8 (4.1) | -0.6 (-2.7–1.5) | 0.14 (-0.35–0.62) |
|
| ||||||
| T1 | 33 | 6.9 (3.5) | 33 | 7.3 (3.0) | ||
| T2 | 27 | 6.1 (3.2) | 28 | 7.0 (3.9) | -0.7 (-2.5–1.1) | 0.20 (-0.30–0.68) |
| T3 | 28 | 5.8 (3.7) | 29 | 6.1 (3.1) | -0.4 (-2.1–1.3) | 0.11 (-0.37–0.59) |
|
| ||||||
| T1 | 33 | 12.3 (6.2) | 33 | 11.8 (6.4) | ||
| T2 | 27 | 9.6 (6.7) | 28 | 11.7 (6.1) | -2.0 (-5.0–1.0) | 0.32 (-0.16–0.81) |
| T3 | 28 | 8.6 (6.4) | 29 | 10.9 (5.9) | -2.3 (-5.7–1.0) | 0.34 (-0.15–0.83) |
|
| ||||||
| T1 | 33 | 20.9 (12.5) | 33 | 21.1 (11.1) | ||
| T2 | 27 | 18.1 (12.3) | 28 | 20.5 (12.0) | -3.2 (-9.2–2.7) | 0.27 (-0.22–0.75) |
| T3 | 28 | 17.1 (12.1) | 29 | 20.4 (11.0) | -3.7 (-9.7–2.3) | 0.30 (-0.19–0.79) |
|
| ||||||
| T1 | 33 | 113.5 (13.7) | 33 | 115.5 (12.0) | ||
| T2 | 27 | 115.3 (10.8) | 28 | 115.9 (13.4) | -1.4 (-7.8–4.9) | 0.11 (-0.37–0.59) |
| T3 | 28 | 115.5 (14.6) | 29 | 113.7 (15.1) | 0.0 (-7.8–7.7) | 0.00 (-0.48–0.48) |
IG, intervention group; CG, control group; SD, standard deviation; CI, confidence interval; T1, Baseline assessment; T2, 1-month follow-up assessment; T3, 3-months follow-up assessment; PSQI, Pittsburgh Sleep Quality Index (.
Figure 2Model-based estimates of the Insomnia Severity Index scores (82) in the intervention group (IG) and control group (CG) at Baseline (T1), 1-month follow-up assessment (T2), and 3-months follow-up assessment (T3). The model includes the factors time, group, and their interaction. The error bars represent the estimated standard error of the mean.